alpelisib 200 MG Oral Tablet [Vijoice]

RxNorm concept 2598469, branded drug (sbd). Prescribable name: Vijoice 200 MG Oral Tablet.

RxCUI: 2598469
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2598469 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

alpelisib 2169285

Other names

Vijoice 200 MG Oral Tablet

Related concepts

alpelisib 200 MG (SCDC, consists of)
alpelisib 200 MG [Vijoice] (SBDC, consists of)
{28 (alpelisib 200 MG Oral Tablet [Vijoice]) / 28 (alpelisib 50 MG Oral Tablet [Vijoice]) } Pack [Vijoice 250 MG 28 Day] (BPCK, contained in)
Oral Tablet (DF, has dose form)
Vijoice (BN, has ingredient)
alpelisib 200 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2598469 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2598469 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2598469. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.